nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.

Young R, Mainwaring P, Clingan P, Parnis FX, Asghari G, Beale P, Aly A, Botteman M, Romano A, Ferrara S, Margunato-Debay S, Harris M

Open source

DOI: 10.1111/ajco.12999
Published: 2018 Oct
Container: Asia-Pacific journal of clinical oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ajco.12999,
  title = {nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.},
  author = {Young R and Mainwaring P and Clingan P and Parnis FX and Asghari G and Beale P and Aly A and Botteman M and Romano A and Ferrara S and Margunato-Debay S and Harris M},
  year = {2018},
  journal = {Asia-Pacific journal of clinical oncology},
  doi = {10.1111/ajco.12999},
  url = {https://doi.org/10.1111/ajco.12999}
}

RIS

TY  - JOUR
TI  - nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.
AU  - Young R
AU  - Mainwaring P
AU  - Clingan P
AU  - Parnis FX
AU  - Asghari G
AU  - Beale P
AU  - Aly A
AU  - Botteman M
AU  - Romano A
AU  - Ferrara S
AU  - Margunato-Debay S
AU  - Harris M
PY  - 2018
JO  - Asia-Pacific journal of clinical oncology
DO  - 10.1111/ajco.12999
UR  - https://doi.org/10.1111/ajco.12999
ER  -

APA

R, Y., P, M., P, C., FX, P., G, A., P, B., A, A., M, B., A, R., S, F., S, M., & M, H. (2018). nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.. Asia-Pacific journal of clinical oncology. https://doi.org/10.1111/ajco.12999

Source records

pubmed · retrieved 2026-09-25T11:23:56.279Z